An NMR Study of the Bortezomib Degradation under Clinical Use Conditions
Figure 3
Two possible degradation processes of BTZ in its pharmaceutical solution form (a) degradation pathway of
boronic amino acids in presence of water or other nucleophilic agents; (b)
oxidative degradation pathway of boronic acids.
